Recombinant Tafazzin (TAZ)

CMD3A; EFE2; EFE; BTHS; XAP-2; G4.5; Barth syndrome; Endocardial Fibroelastosis 2; Cardiomyopathy,Dilated 3A(X-Linked)

  • Recombinant Tafazzin (TAZ) Packages (Simulation)
  • Recombinant Tafazzin (TAZ) Packages (Simulation)
  • RPE564Hu01.jpg SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SEQUENCE of the Recombinant Tafazzin (TAZ)

USAGE of the Recombinant Tafazzin (TAZ)

Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

STORAGE of the Recombinant Tafazzin (TAZ)

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY of the Recombinant Tafazzin (TAZ)

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
RPE564Hu01 Recombinant Tafazzin (TAZ) Positive Control; Immunogen; SDS-PAGE; WB.
PAE564Hu01 Polyclonal Antibody to Tafazzin (TAZ) WB; IHC
MAE564Hu21 Monoclonal Antibody to Tafazzin (TAZ) WB; IHC; ICC; IP.
SEE564Hu ELISA Kit for Tafazzin (TAZ) Enzyme-linked immunosorbent assay for Antigen Detection.
LME564Hu Multiplex Assay Kit for Tafazzin (TAZ) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
GUESTBOOK